The bill, S.B. No. 2336, amends the Texas Pharmaceutical Initiative by expanding the governing board from three to five members appointed by the governor. It introduces new provisions regarding the terms and vacancies of board members, establishing staggered six-year terms with one-third of the members' terms expiring on February 1 of each odd-numbered year. Additionally, it specifies that any vacancies on the board will be filled for the unexpired term in the same manner as the original appointment.

The bill also updates the timeline for the board to prepare and submit a business plan, changing the deadline from October 1, 2024, to June 1 of each even-numbered year. Furthermore, it repeals Section 2177.010 of the Government Code. The governor is tasked with appointing the new board members as soon as practicable after the bill's effective date, with specific terms set for the initial appointments. The act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: Government Code 2177.003, Government Code 2177.006, Government Code 2177.010 (Government Code 2177)